Patents-Review.com
🔗 Permalink
Inventor profile of:

Kieron E. Wesson

City:

Burlingame, California

Country:

United States

Published Applications:

23

Last publication date:

2022-06-30

Top Assignees for applications by Kieron E. Wesson

The entities that hold a legal rights for patent applications filed by inventor Wesson Kieron E.:

Recent patent applications by Wesson Kieron E.

Kieron E. Wesson from Burlingame, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-06-30
US20220204469A1
Chemistry; metallurgy

PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES

 #2 | 2021-06-17
US20210179542A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #3 | 2019-09-05
US20190270699A1
Chemistry; metallurgy

4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #4 | 2019-01-03
US20190002428A1
Chemistry; metallurgy

Process for the production of alpha-tocotrienol and derivatives

 #5 | 2017-11-02
US20170313649A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #6 | 2016-03-17
US20160075638A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #7 | 2016-01-28
US20160024085A1
Chemistry; metallurgy

Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders

 #8 | 2015-10-22
US20150297551A1
Human necessities

(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases

 #9 | 2014-12-25
US20140378453A1
Chemistry; metallurgy

2-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

 #10 | 2014-11-06
US20140329860A1
Chemistry; metallurgy

2-substituted--quinone derivatives for treatment of oxidative stress diseases

 #11 | 2014-10-30
US20140323509A1
Chemistry; metallurgy

2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

 #12 | 2014-08-07
US20140221674A1
Chemistry; metallurgy

PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES

 #13 | 2013-10-31
US20130289034A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #14 | 2013-06-20
US20130157298A1
Chemistry; metallurgy

2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors

 #15 | 2012-05-24
US20120130093A1
Chemistry; metallurgy

Process for the production of alpha-tocotrienol and derivatives

 #16 | 2012-05-17
US20120122934A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #17 | 2011-11-03
US20110269806A1
Chemistry; metallurgy

2-(2-hydroxybiphenyl-3-yl)-1-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors

 #18 | 2011-09-08
US20110218208A1
Chemistry; metallurgy

2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

 #19 | 2011-05-26
US20110124679A1
Chemistry; metallurgy

2-substituted--quinone derivatives for treatment of oxidative stress diseases

 #20 | 2011-02-24
US20110046219A1
Human necessities

(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases

 #21 | 2010-04-29
US20100105930A1
Chemistry; metallurgy

Process for the production of alpha-tocotrienol and derivatives

 #22 | 2010-02-04
US20100029706A1
Human necessities

HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS

 #23 | 2009-05-07
US20090118257A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
InventorID:

299826 ⎘